en

PRODUCT DETAIL

Ropivacaine Kabi 7,5 mg/ml injekčný roztok

Code 0618E
MA number 01/0111/22-S
Product Form: sol inj 1x20 ml/150 mg (amp. PP)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Mutual recognition procedure
Therapeutic Class: 01 - ANAESTHETICA (LOKÁLNE)
ATC:
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BB Amides
N01BB09 Ropivacaine
Shelf life: 36
Container: ampoule PP
Route of admin.: Perineural and epidural use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.04.2022
Validity: 29.04.2027
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Ropivacaine-2mg-7.5mg-10mg-sol inj_06_2022.pdf  
PIL: PIL_Ropivacaine-2mg-7.5mg-10mg-sol inj_06_2022.pdf  
Safety feature Yes
Data update: 05.05.2022
eu-flag.png sk-flag.png